Skip to main content

INFLUENCIA DEL ALCOHOL EN LOS EFECTOS PSICOESTIMULANTES, NEUROTOXICOS Y REFORZADORES DE UNA NUEVA DROGA DE DISEÑO, LA MEFEDRONA, EN RATAS ADOLESCENTES

SAF2013-46135-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction

  • López-Arnau, Raul
  • Buenrostro-Jáuregui, Mario
  • Muñoz-Villegas, Patricia
  • Rodríguez-Morató, Jose, 1987-
  • Ciudad-Roberts, Andrés
  • Duart, L.
  • Camarasa, Jordi
  • Torre Fornell, Rafael de la
  • Pubill, David
  • Escubedo, Elena
Methylenedioxypyrovalerone (MDPV) is a new psychostimulant cathinone acting as a selective dopamine transporter blocker. Due to the concomitant consumption of ethanol (EtOH) and new psychoactive substances, it is of interest to explore a possible pharmacological interaction between MDPV and EtOH. In locomotor activity assays, EtOH (1g/kg i.p.) elicited a reduction in the stimulant effect induced by low doses of MDPV (0.1-0.3mg/kg, s.c.) in rats, jointly with a decrease in blood and brain MDPV concentrations. Experiments in rat liver microsomes showed different effects depending on the [MDPV]/[EtOH] relationship, evidencing, at certain concentrations, the enhancing effect of EtOH on MDPV metabolism. These suggest that EtOH interacts with MDPV at microsomal level, increasing its metabolic rate. The interaction between both substances was also supported by results in plasma EtOH concentration, which were significantly increased by MDPV, in such a manner that EtOH elimination rate was significantly reduced. The possible toxicological impact of this phenomenon deserves further investigation. In contrast, the rewarding properties of MDPV were unaltered by EtOH. Microdialysis experiments verified that, in the NAcc, both substances could also act synergistically, in such a manner that extracellular dopamine concentrations are maintained. Finally, if the psychostimulant effect induced by MDPV decreased with EtOH, it could favor the boosting and re-dosing in search of the desired effects. However, as the rewarding effect of each dose of the substance would not decrease, the addictive liability could increase considerably. Moreover, we must warn about the increase in EtOH concentrations when consumed concomitantly with MDPV., Funding for this study was provided by Ministerio de Economia y Competitividad (grants number SAF2013-46135-P and SAF2016-75347-R) and CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03/0028) (CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain). MB-J and PM-V are post-doctoral fellows (CONACyT post-doctoral grants 263473 and 265633).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction

  • López-Arnau, Raul
  • Buenrostro-Jáuregui, Mario
  • Muñoz-Villegas, Patricia
  • Rodríguez-Morató, Jose, 1987-
  • Ciudad-Roberts, Andrés
  • Duart, L.
  • Camarasa, Jordi
  • Torre Fornell, Rafael de la
  • Pubill, David
  • Escubedo, Elena
Methylenedioxypyrovalerone (MDPV) is a new psychostimulant cathinone acting as a selective dopamine transporter blocker. Due to the concomitant consumption of ethanol (EtOH) and new psychoactive substances, it is of interest to explore a possible pharmacological interaction between MDPV and EtOH. In locomotor activity assays, EtOH (1g/kg i.p.) elicited a reduction in the stimulant effect induced by low doses of MDPV (0.1-0.3mg/kg, s.c.) in rats, jointly with a decrease in blood and brain MDPV concentrations. Experiments in rat liver microsomes showed different effects depending on the [MDPV]/[EtOH] relationship, evidencing, at certain concentrations, the enhancing effect of EtOH on MDPV metabolism. These suggest that EtOH interacts with MDPV at microsomal level, increasing its metabolic rate. The interaction between both substances was also supported by results in plasma EtOH concentration, which were significantly increased by MDPV, in such a manner that EtOH elimination rate was significantly reduced. The possible toxicological impact of this phenomenon deserves further investigation. In contrast, the rewarding properties of MDPV were unaltered by EtOH. Microdialysis experiments verified that, in the NAcc, both substances could also act synergistically, in such a manner that extracellular dopamine concentrations are maintained. Finally, if the psychostimulant effect induced by MDPV decreased with EtOH, it could favor the boosting and re-dosing in search of the desired effects. However, as the rewarding effect of each dose of the substance would not decrease, the addictive liability could increase considerably. Moreover, we must warn about the increase in EtOH concentrations when consumed concomitantly with MDPV., Funding for this study was provided by Ministerio de Economia y Competitividad (grants number SAF2013-46135-P and SAF2016-75347-R) and CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03/0028) (CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain). MB-J and PM-V are post-doctoral fellows (CONACyT post-doctoral grants 263473 and 265633).